Models with clinically-relevant and life-threatening histamine-related cardiovascular disturbances: Evaluation of the clinical effectiveness of H-1/H-2-histamine receptor antagonists in perioperative histamine release

被引：0

作者：

Kunneke, M

Stinner, B

Duda, D

Hasse, C

Lorenz, W

机构：

[1] UNIV MARBURG,CTR OPERAT MED 1,INST THEORET SURG,D-35033 MARBURG,GERMANY

[2] UNIV MARBURG,CTR OPERAT MED 1,CLIN GEN SURG,D-35033 MARBURG,GERMANY

[3] UNIV MAINZ,CLIN ANAESTHESIOL,W-6500 MAINZ,GERMANY

来源：

INFLAMMATION RESEARCH | 1996年 / 45卷

关键词：

D O I：

暂无

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：S44 / S45

页数：2

共 50 条

[21] SIGNIFICANCE OF HISTAMINE FORMATION AND RELEASE IN ENDOTOXIN-SHOCK - HYPOTHESES FOR GLUCOCORTICOID ACTION AND THERAPEUTIC POSSIBILITIES FOR H-1 AND H-2-RECEPTOR ANTAGONISTS
NEUGEBAUER, E
MAROSKE, D
LORENZ, W
BECKURTS, T
MERTE, H
ANAESTHESIST, 1986, 35 (07): : 437 - 439
[22] Pharmacological properties of cardiovascular histamine H-1 receptor binding sites: Characterisation with 2-phenylhistamines
CarmanKrzan, M
Krzan, M
Schunack, W
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 431 - 437
[23] α-methyl-2-phenylhistamines and chiraprodifens:: The first discriminating histamine-related enantiomeric H1-receptor agonists
Elz, S
Kunze, M
Striegl, B
Seifert, R
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 35 - 35
[24] HISTAMINE-RECEPTOR ANTAGONISTS (H-1, H-2) AND THE DEVELOPMENT OF ENDOTOXIN-SHOCK IN THE CONSCIOUS, UNRESTRAINED RAT
BRACKETT, DJ
SCHAEFER, CF
TOMPKINS, P
WILSON, MF
CIRCULATORY SHOCK, 1983, 10 (03) : 250 - 250
[25] EFFECT OF H-1 AND H-2 RECEPTOR ANTAGONISTS ON BRONCHIAL DOSE-RESPONSE CURVES TO HISTAMINE IN NORMAL SUBJECTS
EISER, NM
GUZ, A
SNASHALL, PD
CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1978, 54 (02): : P10 - P11
[26] EFFECT OF COMBINED H-1 AND H-2 HISTAMINE-RECEPTOR ANTAGONISTS ON LATE ASTHMATIC RESPONSE IN AN ASTHMATIC PATIENT
NAKAZAWA, T
UMEGAE, Y
MATSUI, S
FUEKI, R
KOBAYASHI, S
JOURNAL OF ASTHMA, 1987, 24 (06) : 323 - 325
[27] HISTAMINE-RELEASE IN RHEUMATOID-ARTHRITIS AND POSSIBLE CLINICAL EFFECT OF H-2 AND H-1 ANTIHISTAMINES
NORN, S
SKOV, PS
PERMIN, H
WIIK, A
ANDERSEN, V
ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1981, 49 : 64 - 64
[28] ISOCYTOSINE H2-RECEPTOR HISTAMINE-ANTAGONISTS .2. SYNTHESIS AND EVALUATION OF BIOLOGICAL-ACTIVITY AT HISTAMINE H1-RECEPTOR AND H2-RECEPTOR OF 5-(HETEROCYCLYL)METHYLISOCYTOSINES
BROWN, TH
BLAKEMORE, RC
BLURTON, P
DURANT, GJ
GANELLIN, CR
PARSONS, ME
RASMUSSEN, AC
RAWLINGS, DA
WALKER, TF
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1989, 24 (01) : 65 - 72
[29] POTENTIAL HISTAMINE H2-RECEPTOR ANTAGONISTS - SYNTHESIS, STRUCTURE AND ACTIVITY OF A FEW OPEN MODELS RELATED TO CLASSICAL H2-ANTAGONISTS
SORBA, G
FRUTTERO, R
GASCO, A
ORSETTI, M
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1989, 39-2 (09): : 1092 - 1096
[30] STUDIES ON HISTAMINE H-2 RECEPTORS COUPLED TO CARDIAC ADENYLATE-CYCLASE - BLOCKADE BY H-2 AND H-1 RECEPTOR ANTAGONISTS
JOHNSON, CL
WEINSTEIN, H
GREEN, JP
MOLECULAR PHARMACOLOGY, 1979, 16 (02) : 417 - 428

← 1 2 3 4 5 →